Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05080166
NA

UPLYFT For Lymphoma Survivors

Sponsor: Dana-Farber Cancer Institute

View on ClinicalTrials.gov

Summary

The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.

Official title: An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

74

Start Date

2022-02-08

Completion Date

2026-08-31

Last Updated

2026-02-24

Healthy Volunteers

No

Interventions

OTHER

Interview with Clinicians

One time, qualitative interview of clinicians for feedback on UPLYFT intervention

OTHER

Field Test of UPLYFT with Lymphoma Survivors

6 session of UPLYFT intervention with Lymphoma Survivors for feedback

BEHAVIORAL

Pilot of UPLYFT with Lymphoma Survivors

6 session of UPLYFT intervention with Lymphoma Survivors

Locations (1)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States